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1. Introduction 
The lack of a comprehensive aetiology for prostate cancer (CaP), and the need for an effective 
and inexpensive biological treatment modality, devoid of side-effects has resulted in a 
multitude of therapeutic trials. None of these has been very satisfying, and they have vaned 
from focal to invasive therapies for CaP. The progress has been delayed and hampered by the 
lack of any thorough effort to elucidate the cause of the disease. Such efforts would have 
speeded up the introduction of more rational therapy modalities. The different incidence of 
CaP in populations aroused our interest to proceed in a more physiologic way to empirically 
test different functional f factors, since they are non-toxic, although such an approach is 
consuming time. It was ethical to test the effect of these natural alimentary components, and 
follow the patients´ reaction and laboratory responses. Huggins and Hodges1 had already, in 
1941, decisively proven that CaP was a hormone dependent disease, although castration alone 
was not curative. In 1945 Huggins and Scott performed bilateral adrenalectomies2 after the 
glands were found to produce DHEA, which could be transformed into testosterone, regarded 
to have caused recurrent disease. All patients died in a short time postoperatively. However, 
Huggins did not recognize that this showed the central position the adrenals had in regulating 
prostate cancer. In this paper we shall review some cases of prostate cancer treated patients. 
For these we especially follow the shift in FSH, LH, PRL, DHEA, DHEAS, SHBG, plus PSA. 
The involvement of adrenal glands became evident with an orchiectomized prostate cancer 
patient with excessively high FSH 120 IU/L and immeasurable PSA. In MRI (magnetic 
resolution imaging) there was no pituitary adenoma which could explain this high level, but 
both his adrenal glands were evenly hypertophic. Upon laparatomy the enlargement was due 
to bilateral zona reticularis (ZR) cell proliferation, while the adrenals other cell structures were 
normal. These bluish cells with strong green fluorescence had via the hypothalamus 
stimulated the pituitary to greatly increase FSH and LH, see Case A below with normal 
laboratory ranges displayed (the row at the top in all cases).  
The Importance of adrenal ZR cells is unveiled by: A) their marked proliferation after 
orchiectomy; B) lack of ZR cells in castrated male pigs [eunuchs]; C) markedly decreased 
number of ZR cells in patients succumb-bing to CaP; D) the hormonal effect in extracts 
made from ZR cells of castrated boars; E) rapid lethal out-come if CaP patients after 
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orchiectomy are also adrenalectomized. This operation was conclusively remo-ving the adrenal 
lifesaving functions of unknown fictive factors; Cycloprostatins No. I (increasing FSH-) & 
No. II (increasing PRL-levels). 
 
FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit SHBG PSA 
IU/L IU/L mU/L nmol/L µmol/L nmol/L pg/ml pg/ml µg/L nmol/L µg/L 
1-9 2.5-12 50-300 3.0-17.0 0.5-8.0 9-38 ~60 300-500 16-253 15-55 <4.0 
120 53.8 228 3.2 1.9 0.8 <7.8 330 65 48 <1 
Case A. 
Cancer can be regarded as a complex metabolic deficiency disease. Nutritional therapy has 
few negative side effects, as it is a non-invasive treatment. In traditional Chinese medicine 
feeding patients with exotic herbs could help in curing them. At that time it was impossible 
to analyse the precise functional factors ingested, but we seem now to have reached an 
academic form of traditional Chinese medicine since we can include specific pure 
alimentary components to construct a supportive curative diet. Spontaneous regression of 
cancer is rare3, and has been called “The metabolic triumph of the host”4. It implies that 
these patients by chance have ingested a complicated combination of bio-modulating 
natural components to regain the internal balance in their diseased body. The curative effect 
does not seem to involve apoptosis5. These observations signify that the complex metabolic 
deficiency triggering cancer, and also genetic weaknesses, can be compensated by feeding 
patients specific functional alimentary components. Strivings to delineate such metabolic 
factors has finally, after over 35 years, resulted in the present possibility to improve cancer 
therapies in a physiologic way - by dietary supplementation. This finding naturally also 
backs screening tests, since overtreatment can now be avoided. The aim of this long empiric 
study was actually to decrease the need for expensive invasive treatments, which are all 
marred by grave side-effects. We will in this article give a short resume´ of how these 
multiple biological factors were found, over the last decades.  
Our cancer therapies usually only try to remove the symptoms by surgery or irradiation, but 
not to correct the actual aetiology, although the most important aim for cancer treatments 
should be to strive to avoid recurrent disease. Therefore there is a natural motivation to 
apply active bio-immunotherapy in many cancer forms. Present treatments are like treating 
a scurvy patient by extracting his loose teeth but not giving him vitamin-C!  
Prostate cancer (CaP) is the most common form of malignancy in men. We find 5,000 cases 
per year in Finland, with 800 men succumbing to CaP in great pain due to multiple bone 
metastases. In China and India one million men are diagnosed with CaP every year about 
15% dying of it. Last year approximately 300,000 cases were found in the European Union 
while 200,000 patients were diagnosed in the USA, and 27,000 died of CaP. The yearly 
casualty rate in Germany is 12,000 men, while in England 10,000, and they pass on in a very 
painful way from bone metastases. They should all have a chance to be clinically tested 
whether they have a satisfactory positive response from this physiologic treatment modality 
before they are remitted to different invasive therapies, which are all expensive, not 
physiologic, and cause grave side-effects.  
Over the years, to facilitate the search, we developed working hypotheses to outline the 
meta-bolic regulating codes for our three main forms of cancer5 , schematically presented in 
Fig 1. The diseased body can take up these multiple components and restore the multi-
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factorial balance securing normal health. Basically the elementary compounds are composed 
by natural organic and inorganic and neurogenic lipid molecules forming the correction of 
multifactorail deficiency disease/cancer. These components are; amino acids, essential trace-
element ions, vitamins and lipids. 
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Fig. 1. The hypothetic cell regulatory code for our three main forms of cancer; leukaemia, 
adenocarcinoma, sarcoma. The combined effect of amino acids, trace element ions and lipids 
involved in the inductional control mitochondrial Regulation, epigenesist, immune reactions 
secure normal health. 
The incidence of CaP has increased world-wide, and already 5000 new cases were 
diagnosed in Finland last year, and 800 died in intensive pain due to incurable bone 
metastases. In China and India 1 million cases are detected yearly, while 300,000 in the 
European Union, and 200,000 in USA, of which 40,000 and 27,000 respectively succumb to 
this painful disease. This high incidence has naturally led to a lot of therapeutic trials. None 
of these treatments for CaP has been completely satisfactory.  
An economical, biological treatment modality which does not cause side-effects seems 
therefore to be urgently needed. This suggested physiologic dietary therapy is 
inexpensive devoid of side-effects and has the potential to contribute significantly to a 
comprehensive response to cancer. Curative clinical results obtained by feeding patients 
with exotic herbs in traditional Chinese medicine have given a positive clinical results, 
and must be regarded as a clear signal that mammals have a physiologic capacity to 
reverse malignant cells back into healthy transcription without apoptosis. In modern 
biotherapy this biological effect can be simulated by a balanced oral intake of the 
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numerous missing alimentary components, in pure form. They act as a specific functional 
food. The regulating code is certainly more complex than the iodine deficiency causing 
endemic goitre. Our studies have indicated that co-operation by several organs is 
involved with the adrenal glands in a central position6,7. Figure 2. These unknown human 
adrenal biological factors are harboured in zona reticularis cells and they can be activated 
by feeding the alimentary components,8 listed in Table 1. 
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Fig. 2. A schematic "organ cycle" controlling cancer of prostate gland. Adrenal 
zonareticularis (ZR) cells are in a central position responsible for keeping prostate cells in 
normal function. 
1.1 Present prostate cancer treatments 
Prostatectomy, External Beam Radiation therapy (EBRT), Brachytherapy (intensity 
modulated), Three – Dimensional conformal, Low-Dose Brachytherpy, Cryotherapy, Local 
therapy, Lumpectomy, Systemic Therapy LHRH analogue implants, ADT androgen depletion 
therapy, Watchful Waiting,High-intensity focused ultrasound (HIFU) therapy, Vascular - 
Targeted (VTP), Photodynamic Therapy (PTD) using light-sensitive agents with local laser 
activation, leading to cell-destruction, Nonspecific dietary therapy (except a la, Tallberg), BMI 
risk, 5-alpha I & II reductase inhibition (Dutasterid, Proscar, Finasterid), Robotic-Assisted 
Radical Prostatectomy, Hyperthermia, Immune therapy, Life-style Trial, etc.  
1.2 Adverse effects of treatments 
Anaemia, Cognitive decline, Depression, Erectile dysfunction /libido loss, Fatigue / General 
weakness, Gastrointestinal symptoms, Gynecomastia, Bone fractures, hormonally related, 
Hot flashes, Lipid abnormalities, Osteoporosis, Weight gain/redistribution, Muscle wasting, 
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Increased fat deposition, General decrease in quality of life, and Marital Problems due to the 
hormone therapy, Stress, etc. 
1.3 Clinical results 
A regression of cancer reveal that cancer this complex chronic metabolic deficiency disease, 
may be cured by non-toxic dietary restoration of the healthy internal bodily milieu of the 
patient 54,5. Specific mitochondria restore tumour cells to normal healthy transcription 
without apoptosis or cell destruction6. The incentive to try to delineate certain of the 
physiologic factors entailed in malignant transformation of patients suffering from CaP was 
bearing successful clinical results obtained with bio-immunotherapy for renal cancer9, 
cutaneous and choroideal melanoma8 in bio-immunotherapy. A positive clinical effect 
implicated a combined effect caused by specific metabolic dietary substitution, supported by 
specific active immunological stimulation of the patients’ immune defense. The vaccine 
made from the patient´s own tumour tissue will be directed against autologous antigenic 
markers, representing the finger print of pertinent tumour markers9. For prostate cancer 
active immunotherapy is not prescribed since PSA is a serine protease metabolite, and not a 
true tumour marker. PSA could decline during immunization but the PSA antibody titer 
had not sufficient capacity and therefore PSA regained pathologic levels after 8 months10. 
2. Dietary amino acids in attempts to correct the metabolic deficiency 
causing cancer 
The causes of CaP seem rather to be environmental than genetic, and dietary habits have a 
pronounced effect on prostate cancer incidence. The low incidence of CaP in Japan and Italy 
may be linked to the local ingestion of the amino acid serine (Ser) contained in soy and 
parmesan in Italy, further supported by the vitamin-like substance lycopene contained in 
tomatoes. The original idea that cancer represented a deficiency disease affecting amino 
acids was presented by Dr Howard Beard, already in 1941- 4211,12. He could cause 
impressive regression of established sarcoma in rats from daily injections of the three basic 
amino acids (Arg, His, Lys). Our efforts were, therefore, based on studies on the effect of 
natural non-toxic alimentary components. The effect, based on our rat leukaemia model, 
showed that the regulatory code was completely different from that of sarcoma. In both 
experimental models there was, however, a trend effect caused by feeding rats with 
Threonine (Thr) and Serine (Ser). Our efforts were therefore based on studies on the effect of 
natural non-toxic alimentary components.  
The effect, based on our rat leukaemia model, showed that the regulatory code was 
completely different from that of sarcoma. If patients ingest the natural amino acid Ser, PSA 
which actually is a serine protease - the PSA activity declines. The Ser absorbed into the 
patients´ blood decreases PSA, through substrate inhibition. This is more physiologic and 
effective than the tyrosinase inhi-bition caused by Glivec. This stimulated our interest to 
advance in a more physiologic and rational way, selectively feeding patients natural 
alimentary factors and analysing the effect on CaP, although it would take a long time to 
delineate pertinent physiologic metabolic factors, linked to the hormonal balance. Huggins 
and Hodges had decisively proved that CaP was a hormone depen-dent disease, although 
castration as a single treatment was not curative1. 
Spontaneous cures of cancer are so rare because the etiological dietary deficiency leading to 
cancer is more complex than the simple lack of iodine causing endemic goitre. The statistical 
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chance of getting multiple components in the right proportion, and long enough, to 
compensate a longstanding metabolic deficiency is extremely small without external active 
help. These positive findings based on dietary effects should lead us to a new paradigm for 
cancer therapies founded on restoring the physiological internal balance of the body. It has 
really improved our under-standing and biological means for treatment and prophylaxis of 
malignant cell proliferation. We are optimistically reforming prevailing toxic clinical 
treatment modalities, based on mistaken paradigm to kill all cancer cells with cytostatics 
instead of trying to regain the curative healthy internal balance.  
The lack of an effective biological non-invasive treatment alternative, has led to the risk of 
over-treating patients. Our standard therapies are un-physiologic, and few methods are 
curative if app-lied in an advanced stage of CaP. The lack of aetiological understanding has 
led to a multitude of not well founded therapeutic trials. The progress has been hampered 
by the lack of thorough strivings to elucidate the cause of the disease. Such efforts would 
have made it possible more rapidly to find rational therapy modalities. The aim of our 
study, for over 35 years, has therefore been to clarify aetiology and prognostic traits in 
patients’ suffering from different stages of pros-tate cancer. A better understanding of the 
causes for CaP could improve biological treatments and dietary schedules13. Presently, there 
is a new incentive for screening, since there is now an applicable biological treatment for 
CaP. In an early stage, while it still is possible to get a positive clinical response14, patients 
should be tested for their response to this physiologic treatment modality. 
2.1 The importance of administering trace-element ions 
In Dr.H. Beards original studies11,12 causing complete regression of experimental rat sarcoma 
from daily injections of 18 mg of all three basic amino acids (Arg, His, Lys). Regression of 
sarcoma stemmed from a complex formed between the basic amino acids and wolfram (W) 
ions. A related signal system was found with experimental leukaemia. In mammals the 
required trace-element ions were different, Cr and Mn formed the regulating signal with 
Ala, Ile, Leu, & Val preventing induction of leukaemia. In both these studies there was a 
positive trend effect with Serine and Threonine, hinting that the adeno-carcinoma 
regulatory code could comprise supplementation with Ser to male patients, while Threonine 
may be involved in female adeno-carcinoma. The PSA level decreased most likely due to 
substrate inhibition caused by the thus increased level of the natural amino acid Serine in 
the patients´ serum neutralizing his protease enzyme (PSA). We got very valuable support 
from Prof. Klaus Swartz the head of the only trace-element free laboratory in the world in 
Los Angeles. He kindly extrapolated from his rat experiments how much a minimal daily 
amount of essential trace-element ions a human 70 kg body would need. The mg amounts 
and ionic form listed in Table 1 are based on his suggestions.  
An interesting observation was that Strontium may have been involved in regression of 
bone metastases. It was revealed when the ash a patient ingested, whose bone metastases 
had regressed, were analyzed for metals by proton-induced X-ray emission. It revealed that 
he had got 7mg of strontium (+ rubidium and 40 mg Zn daily), in addition to the trace-
element ions we originally used (Table 1). Radioactive strontium was earlier used to scan 
bone-metastases. If repeatedly used it did not work because only ten percent of the i.v. bolus 
(of 85 mg) was actually radioactive. The non-active strontium molecules could block the 
tumour cell receptors and render the scanning unreliable. This is why we presently use 
technetium. It hinted that Sr played a role in the healing system of bone metastases in CaP 
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patients7,15 . Vanadine and Arginine (V & Arg) had previously been shown to arrest bone 
metastases in renal cancer cases16.  
Furthermore, Gly and Glu were fed to act as substrate inhibitors and prevent inflammatory 
reactions in the prostate gland (chronic Pin) caused by splitting the tri-peptide glutathione 
activating the inflammatory leukotriene cascade (Figure 3). Boron (B) is also an inhibitor of 
Gammaglutamyl transpeptidase which splits glutathione and may thus prevent sterile 
inflammatory reactions caused by the Leukotriene - B4, C4, D4 & E4 cascade - ending in the 
slow reacting substance of anaphylaxis (SRS-A)17. 
 
 
Fig. 3. Possible roles of the tri-peptide GSH in arachidonic acid metabolism (1 to 5). GSH 
reduses PGI2 and increases PGE2 formation. PGE2-forming isomerases (3) require GSH as 
essential cofactor (cosubstrate). PGs are involved in the hyperalgesia of inflammation31 
Molybdate (Mo) had an effect on the female menstrual cycle13 to make it completely regular, 
and could perhaps activate a minute oestrogen production even in male patients. Due to 
side-effects oestrogen therapy for CaP has been stopped but a small physiologic stimulation 
may be beneficial? Vanadate together with Arg seemed to prevent and cure bone metastases 
in renal cancer patients and were therefore included as a possible natural co-factor complex 
related to the renal tissue. 
2.2 The importance of administering lipids (CNS) to cancer patients 
The enormous abundance of lipid molecules in the central nervous system (CNS) suggests 
that their role is not limited to be structural and energetic components of cells. Over the last 
decades, some lipids in the CNS have been identified as intracellular signalers, while others 
are known to act as neuromodulators of neurotransmission through binding to specific 
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receptors. Neurotransmitters of lipidic nature, currently known as neurolipids, are 
synthesized during the metabolism of phospholipid precursors present in cell membranes. 
That central nervous lipid molecules were involved in keeping malignant cells in healthy 
transcription was observed already in the seventies11. CNS-lipid molecules were detected by 
thin layer chromatography to be present in the serum of cancer patients, following Herpes 
virus infections. The viral infection had caused lesions in the blood-brain barrier, and vital 
lipids had leaked out into the patients´ blood. The minimal idea was to try to compensate 
this depletion by feeding patients with the lipids they had lost to corrected the depressed 
enzyme activity, on the patients´ buffycoat cells in three days17 and restored his natural 
immunity [lymphopoiesis] thanks to the activity of an un-identified titanium containing 
CNS-lipid molecule. The importance and vital function of millions of CNS-lipids the 
“lipidome” has constantly been overlooked. They have a variety of crucial functions, from 
embryogenesis to securing healthy mental and motor balance as presented earlier 13 . One of 
the most important factors is this Ti containing CNS-lipid, which stimulates the patients´ 
immune reactions and alleviates neurologic pain. These CNS-lipids can be absorbed by 
nerves from the serum and normalize neuronal function. Millions of vital lipids present in 
the CNS can preserve the inductional control over all cells in a cancer patient. Pain is 
actually a warning signal that the nerve tissue cannot produce certain CNS-lipids, but when 
these become available through ingestion they circulate in the blood and are absorbed by 
the nerves, while decreasing the patients´ distress. Following alimentary correction of the 
metabolic deficiency activated cell specific mitochondria can then be seen, by electron 
microscopy, to force cancer cells to regain a healthy form, without apoptosis18, 19. This Bio-
Immunotherapy method has successfully been applied in randomized prospective studies in 
hundreds of patients suffering from melanoma (103 skin + 54 eye)12, or metastasized renal 
cancer (127 cases)15,16 a study was performed at Helsinki University20. 
3. Mitochondrial involvement linked to the healing reaction, without causing 
tumour cell lysis 
The effect of specific dietary supplementation for prostate cancer is usually fairly rapid and 
seen in 6-8 weeks; the laboratory profile is shown here. These transformed mitochondria can 
be revealed since they become electron dense (black) because the enzymes in their crista 
gather significant amounts of metal ions [Cr, Fe, Zn, Ti, & Rb] when they become 
activated6,18. 
 
FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit SHBG PSA 
IU/L IU/L mU/L nmol/L µmol/L nmol/L pg/ml pg/ml µg/L nmol/L µg/L 
1-9 2.5-12 50-300 3.0-17.0 0.5-8.0 9-38 ~60 300-500 16-253 15-55 <4.0 
4.2 4.5 269 2.1 1.5 5.7   130 61 53.7 
7.8 6.9 151 < 2.0 1.3 11.1   149 55 3.7 
Case B. Typical laboratory profiles of a patient on specific functional dietary 
supplementation. FSH and Testosterone increase at the same time as PSA, DHEA, & DHEAS 
declines, indicating a good prognosis. 
A biopsy taken from same lobe as previously showed a Gleason score of 7, revealed in EM 
that the tumour cell nucleus was surrounded by transformed mitochondria, Figure 4. Two 
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of them empty their electron dense activated enzymes into the nucleus when PSA had 
decreased to 3.7 µg/L, and he was clinically in good condition [Magnification x 10,000.]. 
They healed without apoptosis. If the initial PSA level is over 15 ng/mL the therapy has 
usually been started with combined hormone (e.g. LHRH Zoladex 3.6mg for months 
duration) supplemented by dietary measures. When PSA decreases rapidly as in Case B, 
following supplementation with both prostate powders (No1 & No2) in synergy with 
intermittent total anti-androgen blockade (Zoladex, 3.6mg + Androcur, 50mg x 2/day, for 
only 10 days) the PSA-level fell also rapidly from 34.3 ng/mL to 2.3 ng/mL in six weeks. In 
EM the tumour cell nucleus is often seen to be surrounded by transformed mitochondria 
which are electron dense, due to the increased content of Cr,Fe, Zn, Ti, & Rb 18 when the 
tumour progress is arrested Similar mitochondrial transformation with activation in the 
curing phase of mammalian malignant cells, triggered by this physiologic non-toxic biologic 
therapy has been seen in EM with experimental animal models (rat & horse13), in addition to 
episodes with human patients suffering from melanoma, and malignant histiocytoma18,22  
 
 
Fig. 4. Electron microscopy showing (magnification 10.000) with electron dense organ 
specific mitochondria Surrounding the tum cell nucleus when PSA normalized. Two 
mitochondria seem to empty their electron dense material into the nucleus when the patient 
was cured, without apoptosis. 
4. Adverse effects caused by certain biological components 
Alanine administration may increase the PSA-level and food items high in Ala should be 
avoided. Administration of DHEA 25mg per day is definitely contraindicated since it led to 
intensive pain and the patient died in three weeks from multiple bone metastases. Hormone 
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refractory prostate cancer (HRPC) is not due to the emergence and selection of a hormone 
refractory cell clone. It seems to be the result of a too intensive LHRH treatment (continuous 
injections with 3 months duration) when the hormone therapy has been used to reach PSA 
nadir. Instead FSH and LH have decreased to <0.1 IU signaling adrenal feed-back 
exhaustion involving adrenal ZR cell function. The pituitary is not malfunctioning as PRL 
can increase to > 1000 mU/L. A brooding HRPC is seen when PSA, is forced to levels under 
0.9 µg/L, due to excessive anti-androgen therapy, while PRL exceeds 600 mU/L indicating 
that the pituitary is not exhausted. 
5. Attempts to actively increase FSH and PRL in patients, or the use of 
autologous vaccines failed 
The positive prognostic effect of increased FSH- and prolactine (PRL) levels led to 
attempting active stimulation. Ingestion of extracts made from ZR cells of castrated male 
pigs can cause a marginal positive effect on FSH and PRL for a short time but no human 
forensic material was available for testing. Forensic human adrenal ZR-cell extracts should 
be tested as they probably contain these biologic stimulatory factors. If they could be 
characterized it could lead to a natural substitution therapy for CaP, like insulin is for 
diabetics.  
Daily Injections with human FSH (75 -150 U/L) could increase the FSH-level for a short 
time, but would be impracticable in the long run, and too expensive. FSH-releasing factor 
was even less effective. Then again injection of human prolactin PRL or HCG had only a 
marginal effect on PSA. Attempts to externally increase FSH or PRL-levels did not seem to 
be functional. Physiologic stimulation directed at the adrenal glands appears to be the only 
practical therapeutic way.  
Immunisation using autologous tumour polymer particles can decrease PSA-levels for some 
months but is not curative because PSA is only a metabolite, and not a regular tumour 
marker10.  
5.1 Description of some prognostic features in cases of specific dietary 
supplementation for CaP  
The most important laboratory test to be taken immediately when CaP is suspected, or 
actually diagnosed, is to analyze the serum levels of FSH, LH, PRL, DHEA, DHEAS, SHBG, 
and f/t PSA. PSA as a single marker is not alone sufficient, since it can be held down by an 
increased FSH- or PRL-level. A high FSH-level and low DHEAS with decreasing PSA is a 
good prognostic sign, and this effect caused by alimentary supplementation is usually fairly 
rapid. In one patient of the earliest cases found by screening tests his PSA rose from 4.3 
ng/mL to 6.4 in two months with a Gleason of 7. He was then routinely scheduled for 
prostatectomy. With informed consent he preferred to test this biological alternative, 
safeguarded by regular PSA controls, and immediate change back to the invasive treatment 
option if his PSA rose. On a double dietary daily dose and CNS-lipids, his PSA declined to 
2.3 ng/mL in half a year, followed by diminished urinary distress, and without any side-
effects. He opted then to take the prostate supplements only once a day. In half a year his 
PSA had once more started to rise and the double dose was reinitiated. The dose response 
was again positive, as his PSA-level declined to normal levels. His CaP became then stable 
for 6 years in continuous dietary therapy, but a slight increase in his PSA-level was seen 
(from 6 – 7 ng/mL over four months), when Arg substitution had been stopped for some 
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time. This was to test if this component really was necessary to keep his PSA-level stable. 
The urologists persuaded him then immediately to accept prostatectomy, although we 
would have preferred to reinstate Arg to see if it would reduce PSA anew. His 
prostatectomy specimen showed that his Gleason score had declined to 4, and no growth of 
the prostate tumour tissue had occurred. This unnecessary operation stopped anyhow 
further biological treatment for CaP, as all tumour cells had been removed. We did not pay 
sufficient attention to the fact that this patient had, before his prostate cancer was 
diagnosed, also suffered from Crohn´s disease, however, most clinical symptoms had almost 
disappeared during his biological treatment for CaP23. Four years later his symptoms of 
Crohn´s disease of Crohn’s had recurred, and he was consequently operated for colon 
cancer. This awoke our interest for sterile inflammatory diseases like, ulcerative colitis, 
rheuma, fibromyalgy, psoriasis polyarthritis24 etc. The probable common denominator was 
the effect caused by supplementation with CNS-lipids which we had included to quell 
chronic prostatitis as a precancerous state for CaP. Administration of this lymphopoietic, Ti 
containing CNS-lipid molecule was aimed to normalize inflammatory reactions with the aid 
of this vitamin-like CNS factor, which now also seemed to affect other sterile inflammatory 
diatheses, as mentioned above.  
In some patients the effect of a sole dietary supplementation is slow and protracted as 
shown in Case C. In this case ingestion of prostate powders (our cocktails) 1/day, 
alternatively 2/day, and CNS-lipids increased slowly the patients FSH- and LH-levels & 
constantly low DHEAS and rising testoteron while PSA is low, in the normal range. Dietary 
supplementation alone has kept him in stable disease, now for over five years. His starting 
Gleason score was 8. 
 
 FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit HBG PSA 
 
IU/ 
L 
IU/
L 
mU/
L 
nmol/
L 
µmol/
L 
nmol/
L 
pg/ 
ml 
pg/ 
ml 
µg/ 
L 
nmol/ 
L 
µg/
L 
 1-9 
2.5-
12 
50-300 3.0-17.0 0.0-8.0 9-38 
~60pg
/ml 
~500pg
/ml 
16-253 15-50 <4.0 
2005 5.4 
<0.0
1 
48 5.5 1.5 4.9   455 77 <0.2 
2006 8.4 2.5 83 3.2 1.2 5.6   376 82 <0.2 
2007 13.8 6.2 114 3.5 1.0 10.2   313 61 0.22 
2010 20.5 12.3 103 3.5 1.1    347 60 0.49 
Case C.  
A positive reparative reaction seems to be flagged by an increase in the FSH- LH- and 
prolactin (PRL) levels. Revelation of these unknown stimulatory factors could form a 
decisive prevention for the emergence of a “hormone refractory state”, leading to 
improvement. 
Case D. This patient was succumbing to CaP, 11.1996, [T4NxM1] with multiple bone met -
11/94] had orchiectomy -94, three years earlier. Initially PSA 92.6 decreased after 
orchiectomy 1994 to 5.7- 5.3 (-95) in combined bio-modulation but without Sr. He stopped 
the intake of all dietary components and became androgen independent (-96). PSA rose to 
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119 ng/mL, and he died showing extreme laboratory values, as measured from a blood 
sample taken the same day before his exitus.  
 
FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit SHBG PSA 
1-9 
2.5-
12 
50-
300 
3.0-
17.0 
0.5-8.0 9-38 ~60 
300-
500 
16-253 15-55 <4 
<0.1 <0.1 1060 7.2 6.8 0.6    2145 364 
Case D.  
The marked increase in PRL affirm that the pituitary function is not depressed and it is 
feverishly trying to save the patient, but without a concomitant FSH increase the case is 
lost.  
His laboratory values have oscillated during all these years but conspicuously FSH has 
stayed high all the time indicating a continuous adrenal feed-back reaction which could 
involve in preventing recurrent disease.  
 
FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit SHBG PSA 
IU/L IU/L mU/L
nmol/
L 
µmol/L
nmol/
L 
pg/ml pg/ml µg/L 
nmol/
L 
µg/L 
1-9 2.5-12 50-300 3.0-17.0 0.5-8.0 9-38 ~60 300-500 16-253 15-55 <4.0 
67-30 37-16 159-95 < 2.0 < 0.8 1.0 < 7.8 330 109-99 58-61 < 0.1 
Case E. CaP detected with PSA 30 µg/L with multiple bone metastases. Orchiectomy was 
performed 1992. Dietary bio-modulation + Strontium (7mg/day) started 1993. His periostal 
pain subsided in four months. All bone metastases disappeared 1996. He is now in excellent 
clinical condition 2011. 
In patients with hurting bone metastases to get these to regress they may need to be 
orchiectomized if during the dietary substitution they have recurrent bone metastases. After 
castration the bone metastases could totally regress in half a year. This improved clinical 
result after recurrent CaP may signal that some factor in the testicular tissue is produced 
which during a prolonged biological therapy may arrest the positive effect of the full dietary 
substitution although it supplies many of the required factors; Sr, V, Ser, Arg etc. If this is 
required in selected cases for s cure it may be worth the castration, a fairly simple operation 
compared to prostatectomy, since the survival time of CaP with multiple hurting bone 
metastases is otherwise only 8 months ?.  
Of the more than ten patients who were orchiectomized , all who not have got any adjuvant 
supportive dietary treatment have died. Some of them lived up to 8 years after castration, 
which is better than Huggins and Hodges got in the early forties. On the contrary, castrated 
patients who continuously have got our supportive metabolic functional alimentary factors 
are alive in good clinical condition, as well as those cases that have not been 
epidydectomized, but have been on dietary supplementation in synergy with short time 
intermittent hormone treatment. In certain cases the continuous hormone treatment with 
LHRH has been possible to stop completely, without leading to recurrent disease, with 
follow-up presently already over 5 years, as in Case B.  
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5.1.1 Short time intermittent hormone treatment blocks hormone refractory prostate 
cancer induction 
Short time intermittent LHRH hormone treatment is definitely recommended as it has 
prevented the development of hormone refractory states. 
 
FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit SHBG PSA 
IU/L IU/L mU/L nmol/L µmol/L nmol/L pg/ml pg/ml µg/L nmol/L µg/L 
1-9 2.5-12 50-300 3.0-17.0 0.0-8.0 9-38 
~60pg/
ml 
~500pg
/ml 
16-253 15-50 <4.0 
(Short time intermittent androgen ablation treatment with Zoladex 3.6mg + cyproteronacetate) 
15.2 16.1 993 3.8 2.4 6.4 75 410 1500 45 13.4 
(Three months after Androcur 50mg x 2/day for 10 days to avoid flare-up after Zoladex 3.6mg injections.) 
4.2 7.3 1490 2.5 1.6 5.8 72 430 1100 2.5  
(Three months later when the activated adrenal feed-back has time to increase FSH and sometimes also PSA) 
15.2 17.7 1520 2.2  < 0.8 76 500 993 14.5  
Case F. Lab assay profiles during recommended short time intermittent LHRH treatment, 
Zoladex 3.6mg,+ Androcur 50mg X2/day with many months intervals, in synergy with 
specific dietary supplements. 
Zoladex 3.6 mg inj can then be repeated, if also PSA has increased as in this case. If PSA 
stays low Zoladex would not need to be repeated as it stays low due to synergy with 
supplementation. One should not strive to reach a PSA nadir. Avoid injection of Zoladex 
10.8mg every third month becau-se the adrenal feed-back will be exhausted, and FSH 
declines to < 1.0ng/mL. This is not due to pituitary dysfunction because PRL can start to 
increase when the body in vain is trying to defend itself (see Case C). This ominous turn is 
not due to selection of a hormone refractory cell clone, but to ZR exhaustion, as the adrenal 
glands have not been allowed to function during a necessary intermission in the hormone 
therapy. If the FSH-level is depressed to under 1 ng/mL it is a signal that the adrenal feed-
back has been exhausted, but not the pituitary since PRL can be markedly increased (600 – 
1060 mU/L), indicating a brooding HRPC. 
Growth factors, activin & inhibin. Dramatic changes were seen after castration, during 
pregnancy and estrogen substitution therapy. CaP diagnosed by soft tissue biopsies had also 
specific profiles Inhibin and activin patterns changed dramatically in patients detected from 
soft tissue metastases, and not from biopsies of their prostate gland. A shift characterized by 
a very depressed inhibin level was seen in castrated patients, as well as during normal 
pregnancy, and in healthy females on estrogen substitution. 
CaP patients diagnosed from the presence of soft tissue metastases represent a special from of 
prostate cancers (possibly neuroendocrine?). They may have markedly high serum activin-
levels ((1890- 2180 pg/ml) paired with low inhibin-levels (25-34 pg/ml). Initially their serum 
ferritin levels are high (1164-2499 µg/ml), while DHEAS (< 0.8 – 1.8) and DHEA (2.2 - 2.4) 
are low. FSH-levels are normal or low (1.9 -5.1 IU/L) while LH-levels are undetectable (<0.1 
IU/L). Case G. had a PSA-level of 10070 µg/L, while the other similar case showed a PSA of 
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246 µg/L. In both patients their PSA decreased to 5.3 µg/L, and 2.1 µg/L respectively in half 
a year, following intermittent short cycle LHRH therapy, in synergy with bio-modulating 
dietary measures. The high activin levels were not appreciably affected by the therapy, 
while PSA was decreased markedly, to normal levels. 
 
FSH LH PRL DHEA DHEAS Testost Inhibin Activin S-Ferrit SHBG PSA 
IU/L IU/L 
mU 
/L 
nmol 
/L 
µmol/L
nmol/
L 
pg/ml pg/ml µg/L 
nmol 
/L 
µg/L 
1-9 2.5-12 
50-
300 
3.0-17.0 0.0-8.0 9-38 
~60pg/
ml 
~500pg
/ml 
16-253 15-50 <4.0 
5.1 <0.1  2.4 1.8 <0.8 25 2900 1164  
10070
.0 
combined hormone and dietary therapy led to CR of metastases (CR) and to normal PSA 
6.2 <0.1     22 2650 316  5.3 
Case G. CaP was detected from neck metastases and he had also bone metastases. A special 
characteristic was extremely high activin- and PSA-levels 10,070 µg/L which decreased to 
5.3 µg/L, in 6 months following combined intermittent short time LHRH plus dietary 
therapy. All soft tissue metastases regressed and he was in good health. 
His extremely high activin 2900 and PSA-level of 10,070 µg/L, decreased in intermittent 
short time hormone therapy to 5.3 µg/L, in 6 months in combined LHRH + biological 
therapy. Patients don’t die of high PSA, but of depressed FSH (< 0.1 ng/mL, due to adrenal 
feed-back exhaustion).  
Orchiectomized CaP patients generate an increase in their FSH-levels to, 40 – 130 IU/L, in 
some months, but show also a characteristically manifestly depressed serum inhibin level 
(<7.8 pg/ml) while their activin level (~ 560 pg/ml) is normal. Surprisingly healthy 
pregnant females revealed a similar change in their inhibin / activin levels, with a correlation 
value of 1:70, until parturiency when the “growing cell-mass” – the healthy child is borne 
and the related value again becomes normal. Alarmingly also estrogen substitution 
(already 50 µg plasters) in postmenopausal women can show a similar dramatic change in 
their inhibin / activin correlation values. Such a provoked change in a females serum 
growth factor levels – usually actively made to last more than nine months by their 
gynaecologists – could easily fool the body that it should produce growing cells. This 
anomalous change may explain the observed increased breast-cancer and lymphoma 
incidence generated by estrogen substitution therapies in otherwise healthy females. The 
effect of estrogen substitution therapy, prescribed to any female patient, should therefore 
obligatory be monitored by inhibin / activin assays, to see if it causes a reaction simulating 
pregnancy, since it may physiologically be misinterpreted, and consequently generate 
proliferating (malignant?) cells. 
The growth factor “activin” is appreciably increased (5-6x) in the serum of patients suffering 
from a rare special form of CaP, primarily diagnosed from soft tissue metastases, and not 
from the prostate gland. Strontium (Sr) is an essential component of the periost, and this 
trace-element is involved in curing bone metastases caused by ingestion of Sr 7mg/day. It 
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has eradicated multiple metastases, now with a follow-up of over eighteen years - without 
recurrent disease. Ingestion of DHEA is contra-indicated since it can activate CaP. 
Autologous vaccines applied for CaP is not cura-tive and has only a short-time effect, since 
PSA is not a regular tumour marker but a metabolite.  
5.2 Unfavorable clinical events 
Excessive hormone treatment is unfavorable, e.g. LHRH analogue treatment using 
continuous injections with three months duration (> 10mg) in an effort to reach a PSA nadir 
exhausts the adrenal feed-back reaction and causes HRPC. FSH will then also decline to < 
1.0 ng/mL. Excessive needle biopsies (12 -24 cores) may spread malignant CaP cells and 
could be the reason for the high recurrency rate of 35 -40 % following prostatectomies 25 . 
The use of specific serum markers 26 , MIR, PSA velocity etc. should decrease the need for 
un-necessary cores, and the few biopsies actually needed should be directed more precisely. 
The side effects with pain, and caused inflammations would diminish. This biological 
treatment schedule would anyway be the same disregarding the numbers of cancer focuses 
in the different lobes of the prostate gland.  
The dietary effect which increases FSH is sometimes protracted. In Case E. it took 9 
months of continuous prostate powder ingestion to cause an increase from 5.4 to 8.4, and 
after 5 years it had risen to 20.5 IU/L. The response to dietary therapy is fairly 
progressive so that one can judge, in months, if the patient will respond to this specific 
dietary supportive therapy based only on standard laboratory tests, FSH increases and 
DHEAS decreases etc. Initially increased FSH or PRL-levels are good prognostic signs and 
should always be analyzed when CaP is found by screening tests, since invasive 
treatments can be avoided. The human adrenal biological factors harbored in the zona 
reticularis (ZR), fictively called cycloprostatin I & II, should be purified from forensic 
healthy human adrenal material aided by assays for their stimulatory effect on the 
pituitary. The clinical use of such purified factors could form a biological compensatory 
medical treatment for CaP. 
 
 
1. Oral administration of each (2-5g/day) of respective L-amino acids; Arg, Asp, Glu, 
Gly, Lys, & Ser, all in connection with meals. 
2. Essential trace-element salts prescribed orally as biologically active ions, at dose 
levels of some milligrams (1-3mg/day); Chromium (CrCl 2.6H2O) 6mg (=1.17 mg Cr), 
Molybdenum (Na 2 MoO4 .2 H 2 O) 4mg ( ≈ 2mg Mo), Rubidium (RbCl2 . 2 H 2 O ) 1-
10mg (≈ 7mg Rb), Tinn (SnCl 4.5H2O) 4mg (=1.35mg Sn), Strontium (SrCl 2) 1-7mg (≈ 
4mg Sr), Vanadine (Na 2VO4.4 H2O), 6mg (= 2.5 mg V), Wolfram (Na 2WO4. 2 H 2O), 
4mg (=2.3mg W), Zink (= Zn 30mg).  
3. Physiologic dosages of vitamins; A,B,C,D,E,K , folic acid and lycopene. 
4. To improve lymphopoiesis and the immune-defence of patients a diet containing 
prion-free neurologic lipids (micro-capsulated CNS-lipids).  
5. Dose-levels are adjusted based on the clinical response as measured during the 
therapy, and correlated to the patients´ body weight.  
6. Transformed organ specific mitochondria participate in the curing phase of CaP. 
Table 1. As Cancer is a complex metabolic deficiency disease it is curable by dietary 
supportive measures.  
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5.2.1 Un-interrupted hormone therapy may cause HRPC, avoided by short time 
intermittent treatment  
The effect of hormone therapy for CaP, in recommended intermittent short time pulses 
combined with metabolic bio-modulation activates a feed-back reaction recorded as 
characteristic changes in the laboratory response profile, with FSH, LH and/or PRL increase 
trailed by DHEAS and PSA decreases, a reaction in which adrenal ZR cells seem to have a 
central regulatory function. Orchiectomy will cause FSH to increase, further accentuated by 
prostatectomy. Prostate cancer patients die in a short time if orchiectomy is followed by 
adrenalectomy which attests the importance of functional adrenal glands. A dramatic rise in 
activin levels is recorded in a special form of CaP, diagnosed in biopsies from soft tissue 
metastases. Inhibin is again remarkably decreased following orchiectomy. A similar 
depressed inhibin level was surprisingly also seen in normal pregnancy, and during the 
popular estrogen substitution therapy. If estrogen substitution in postmenopausal females 
cause a growth factor shift mimicking pregnancy her body may not understand that cells, 
especially malignant cells, should not be allowed to multiply. The increased breast cancer 
incidence may possibly be connected with this unnatural shift in the levels of these, 
inhibin/activin, growth factors 13,15. Patients on estrogen substitution should be tested for 
these growth factor levels to see if they inadvertently have been rendered to belong to a risk 
zone for malignant cell proliferation?  
Complete regression of CaP shows that this complex posses chronic metabolic deficiency 
disease can be treated by non-toxic dietary restoration of the healthy internal milieu in the 
patient activating organ (cell) specific mitochondria to restore normal healthy transcription 
of malignant cells without apoptosis or cell destruction as seen in Figure 4. The 
improvement could be due to activation of cell/organ specific mitochondria which regulate 
the genome, and can force oncogen transcription back to a normal healthy form21, 22. This 
was first seen in rats in which induction of leukaemia was prevented by activated, electron 
dense cell-specific mitochondria functioning at body temperature 18. They were found to lose 
their inductive regulatory potency if stored at +4 ⁰C (because we are warm-bloodied?). The 
enzymes in mitochondrial crista were activated by metal ions; Cr. Fe, Zn, Ti, Rb, and this 
metal increase made them electron dense, and possible to observe by EM22. 
5.2.2 Mitochondria inducing healing, correcting mutations, activation of stem- cells & 
transplantation  
Most of our standard treatments represent a poor practice alternative often in the form of a 
toxic therapy for a complex metabolic deficiency disease, and by only removing the 
symptoms, which make patients prone to suffer recurrent disease in 35 -40% even after 
prostatectomy. Patients who after the operation later on start to show a biochemical increase 
in PSA, supposedly due to a non-radical operation, or to the active spread of malignant cells 
by excessive biopsy cores (12-24). A chronic inflammatory (Pin) reaction may be induced by 
these bloody interventions, and any inflammatory reaction is potentially carcinogenic 23,24 , 
like we see e.g. as a sequel of the lack of a lymphopoietic central nervous lipid molecule - 
linked to titan - resulting in an aberrant immune-response as in; Crohn´s disease, ulcerative 
colitis, rheuma, psoriasis, & fibromyalgy 24,30 etc. This physiologic deficit can be 
compensated by the intake of CNS-lipids (and/or butter) 23,24,30. If these lipid precursors are 
present in the patients´ blood the depletion caused by daily stress can be compensated 
during our sleep.  
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A well directed biopsy core may suffice to evaluate the Gleason score. This functional 
dietary treatment will principally be the same disregarding the number of actual CaP 
focuses.  
6. Conclusion 
The primary effort of this long study was to characterize etiological factors for CaP before 
starting any big randomized series. Instructive features compiled from approximately 70 
patients suffering from different forms and stages of CaP were followed-up for decades. 
This has resulted in a recommendation to apply these findings in a biological treatment 
modality. Understanding of the nature of that particular tumour it can help us to optimize 
therapy or to design therapeutic approaches. Patients after prostatectomy may not respond 
as well to dietary supplementation with activation of the adrenal ZR feed-back cycle, since 
this organ cycle may require or involve also normal pros-tate cells to be fully effective. 
Probably prostatectomy should not be performed before one has had time to evaluate the 
patients´ responses to this physiologic bio-modulating treatment. The positive clinical effect 
of continuous dietary treatment is prolonged, and is today already extending over 19 years 
in a case who initially suffered from multiple hurting bone metastases13 . This beneficial 
adrenal fed-back activation has continuously been stimulated by ingestion of the biological 
factors listed in Table1.  
An efficient biological treatment modality devoid of side effects and economical, will give 
scree-ning for CaP a new rational, since the progress of the disease can now be arrested and 
even bone metastases be cured in a physiologic way. The dispute over the marginal 
improvement in survival rates between patients on Watchful Waiting over cases that are 
prostatectomized could be missed by the fact that neither group has received any biological 
supportive treatment to compensate the actual aetiological metabolic deficiency. And thus 
the surgical removal of symptoms of CaP (i.e. prostatectomy) does not censure the 
aetiological deficiency7, 15.  
The importance of mitochondrial function, linked to the memory of the nucleotide sequence 
in the chromosomes they have created 21 can explain how identical mutations in both 
chromosomes can lead to that 10% of the off-springs have lost the mutation, and are healthy. 
This does not require a change of Mendel´s law since mitochondrial memory could explain 
this surprising result as they correct the mutation during replication 28 ! Correction of the 
fault can occur when mitochondria have a memory of what they have created 21,27. The 
interesting study by Hohlfelds group on paediatric skin burns may be explained by the 
possibility that cell specific mitochondria transgressed from the male skin transplant they 
used into the female receptor-cells, whereby the full genome present in any of her cells 
could transform into her own skin – a “transplant” which cannot be rejected. This represents 
a further step of refined “stem-cell” activation, which is not hemmed by restrictions 
presently affecting stem cell studies 28 . To efficiently learn to use cell-specific mitocho-ndria 
and epigenesis in biology and medicine will be the scientific challenge of this century!  
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